Judy Faulkner

Maybe only two of them have the growth that venture capital is looking for, so they drop the others who then die.

Or private equity comes in later, and private equity often will sell off a lot of the company.

So it looks like their expenses are less.

It looks like they're more profitable.

But really, they've just been mangled.

We don't have many like that.

Just a few, and we're very leery about working with them because we can feel a difference.

We can feel the focus, not on as much helping patients, but much more on making a profit.

No, no.

I'm just laughing.

You know how we sell.

Yeah, so that's how the international goes.

Somebody calls up from the Netherlands and says, can we buy it?

And we say, come visit us.

And they come visit us.

Both in the U.S.

and overseas, we do, yes.

We don't want a client not to be successful.

And if we think they're not going to make it, like, let's say they're too small and the expense and the work effort would be too great, we'll say no to them.

I remember one case a number of years ago where I said, no, you're too small.